Key points from article :
Phase 2 clinical trials are 2 senescent cell treatments, 2 stem cell treatments.
Phase 3 is a TOR inhibitor and a stem cell treatment.
Wnt pathway is fundamental in stem cell differentiation.
Samumed is developing drugs for restoring the Wnt signalling pathway.
TOR inhibitor is used for respiratory tract infections in the elderly, for improving the immune system.